New treatment for adults with chronic lymphocytic leukaemia

NICE is recommending venetoclax with rituximab for adults with relapsed or refractory chronic lymphocytic leukaemia. Thousands of patients should benefit, NICE says.
Source: NHS Networks - Category: UK Health Source Type: news